| 1 | same | 23,627 |
| 2 | abovementioned | 35 |
| 3 | best-studied | 23 |
| 4 | best-documented | 15 |
| 5 | above-described | 10 |
| 6 | fittest | 9 |
| 7 | first-flush | 8 |
| 8 | c-seal | 7 |
| 9 | cbs-qb3 | 6 |
| 10 | δtpia | 6 |
| 11 | 150-mg/day | 5 |
| 12 | afore-mentioned | 5 |
| 13 | bluff | 5 |
| 14 | china-recommended | 5 |
| 15 | e-screen | 5 |
| 16 | best-researched | 4 |
| 17 | cdc/acsm | 4 |
| 18 | mn4cao5 | 4 |
| 19 | most-effective | 4 |
| 20 | onset-to-onset | 4 |
| 21 | ştei-băiţa | 4 |
| 22 | 10-mg/day | 3 |
| 23 | 90-mm | 3 |
| 24 | andon | 3 |
| 25 | apartheid | 3 |
| 26 | blue-field | 3 |
| 27 | cbf-targeted | 3 |
| 28 | form-only | 3 |
| 29 | interwar | 3 |
| 30 | miyahira-araujo | 3 |
| 31 | morning/morning | 3 |
| 32 | newly-discovered | 3 |
| 33 | ravasio | 3 |
| 34 | sigrid | 3 |
| 35 | technische | 3 |
| 36 | trans-amino | 3 |
| 37 | traumaman | 3 |
| 38 | whole-group | 3 |
| 39 | 100-year | 2 |
| 40 | 1600-iu/d | 2 |
| 41 | 18-20-week | 2 |
| 42 | 2-imidazolyl-3,4-dihydroquinazolines | 2 |
| 43 | 21/2/5 | 2 |
| 44 | 3d-rx-system | 2 |
| 45 | 7.47-g | 2 |
| 46 | 746-bp | 2 |
| 47 | 9931 | 2 |
| 48 | al-mu'alajat | 2 |
| 49 | all-placebo | 2 |
| 50 | all-sutures-out | 2 |
| 51 | anatomische | 2 |
| 52 | apoe-apoc1-apoc4-apoc2 | 2 |
| 53 | athas | 2 |
| 54 | attitude-social | 2 |
| 55 | baylor-methodist | 2 |
| 56 | beloved | 2 |
| 57 | bex | 2 |
| 58 | bh4-perfused | 2 |
| 59 | chambery | 2 |
| 60 | closely-supervised | 2 |
| 61 | effect-lasting | 2 |
| 62 | egd-colonoscopy | 2 |
| 63 | firebird2 | 2 |
| 64 | first-person-shooter-video-game | 2 |
| 65 | first-quartile | 2 |
| 66 | fitfor2 | 2 |
| 67 | furopyridine | 2 |
| 68 | half-order | 2 |
| 69 | higher-dosage | 2 |
| 70 | hvj-liposome-carrying | 2 |
| 71 | hypovirus-infected | 2 |
| 72 | inh-rpt | 2 |
| 73 | inter-epidemic | 2 |
| 74 | intial | 2 |
| 75 | irregularly-shaped | 2 |
| 76 | its1/5.8s | 2 |
| 77 | jeryl | 2 |
| 78 | joaquín | 2 |
| 79 | longli | 2 |
| 80 | mapé | 2 |
| 81 | maylard | 2 |
| 82 | neurosky | 2 |
| 83 | nomological | 2 |
| 84 | onderlinge | 2 |
| 85 | ondokuz | 2 |
| 86 | one-needle | 2 |
| 87 | pani-bi₂te₃ | 2 |
| 88 | pre-ischaemic | 2 |
| 89 | pre-vte | 2 |
| 90 | premicellar | 2 |
| 91 | pyloriset | 2 |
| 92 | r-packages | 2 |
| 93 | raison | 2 |
| 94 | rbv-containing | 2 |
| 95 | remigium | 2 |
| 96 | resistance-band | 2 |
| 97 | senescing | 2 |
| 98 | signature™ | 2 |
| 99 | smetankin | 2 |
| 100 | spma-spmb | 2 |
| 101 | stmp-treated | 2 |
| 102 | syntax-le | 2 |
| 103 | teamstepps | 2 |
| 104 | toruzyme | 2 |
| 105 | traumaregistry | 2 |
| 106 | trec-enriched | 2 |
| 107 | venotrain | 2 |
| 108 | vibration-to-translation | 2 |
| 109 | want2work | 2 |
| 110 | xeni | 2 |
| 111 | zebris | 2 |
| 112 | β-arrestin-2-assembled | 2 |
| 113 | δ0 | 2 |
| 114 | 'bruce | 1 |
| 115 | 'capacidad | 1 |
| 116 | 'maori | 1 |
| 117 | 'modus | 1 |
| 118 | 1.88-ga | 1 |
| 119 | 10,000-step | 1 |
| 120 | 120-question | 1 |
| 121 | 14-3-3γ/star | 1 |
| 122 | 14-3-3ζ-driven | 1 |
| 123 | 14ud | 1 |
| 124 | 1975-80 | 1 |
| 125 | 2-haptic | 1 |
| 126 | 20-mcg | 1 |
| 127 | 270-minute | 1 |
| 128 | 3-deoxy | 1 |
| 129 | 3-phenolic | 1 |
| 130 | 3α-17 | 1 |
| 131 | 3∼5-wk | 1 |
| 132 | 4-methoxycarbonyl-2-nitrophenyl | 1 |
| 133 | 48-th | 1 |
| 134 | 5-fluorouracil/epirubicin/cyclophosphamide | 1 |
| 135 | 500-year-long | 1 |
| 136 | 6.5-week | 1 |
| 137 | 7+3+atra | 1 |
| 138 | 7-hydroxy-n-neopentyl | 1 |
| 139 | aamyc | 1 |
| 140 | acceptor-recognition | 1 |
| 141 | ace.1 | 1 |
| 142 | activity-sensitive | 1 |
| 143 | acute-cyclic | 1 |
| 144 | advaita | 1 |
| 145 | adyayana | 1 |
| 146 | alarme | 1 |
| 147 | ald-enabled | 1 |
| 148 | all-96 | 1 |
| 149 | all-loop | 1 |
| 150 | allophonic | 1 |
| 151 | allyl-modified | 1 |
| 152 | alumina-bearing | 1 |
| 153 | amborella | 1 |
| 154 | amprenavir-ritonavir | 1 |
| 155 | anangu | 1 |
| 156 | anatomy-guided | 1 |
| 157 | anti-h6n1 | 1 |
| 158 | antiprotéases | 1 |
| 159 | aprepitant-containing | 1 |
| 160 | arf-gap | 1 |
| 161 | artiview® | 1 |
| 162 | asia-oceania | 1 |
| 163 | assi | 1 |
| 164 | atazanavir/ritonavir-based | 1 |
| 165 | augmented-correlation | 1 |
| 166 | avoid-intubation | 1 |
| 167 | ba-sic | 1 |
| 168 | bac- | 1 |
| 169 | balke-ware | 1 |
| 170 | barber-based | 1 |
| 171 | baseline/12-month | 1 |
| 172 | batch-sampling | 1 |
| 173 | benthopelagic | 1 |
| 174 | bertinot | 1 |
| 175 | beta-exotoxin | 1 |
| 176 | bewitching | 1 |
| 177 | bfm-95 | 1 |
| 178 | bis-electrophiles | 1 |
| 179 | bittery | 1 |
| 180 | boo-rich | 1 |
| 181 | breakthough | 1 |
| 182 | calcisponge | 1 |
| 183 | callicrate | 1 |
| 184 | carbamazepine-dosing | 1 |
| 185 | carl-gustav | 1 |
| 186 | carnic | 1 |
| 187 | casuistics | 1 |
| 188 | cathetec | 1 |
| 189 | cd33+/hla | 1 |
| 190 | cdc-recommended | 1 |
| 191 | ceausescu | 1 |
| 192 | cenex | 1 |
| 193 | charge-separating | 1 |
| 194 | charoi | 1 |
| 195 | chemotheurapeutic | 1 |
| 196 | clarithromycin-nitroimidazole | 1 |
| 197 | cmv-preventive | 1 |
| 198 | cnrl | 1 |
| 199 | cognition-centered | 1 |
| 200 | coitus-treatment | 1 |
| 201 | compactin-cholestyramine | 1 |
| 202 | comptes | 1 |
| 203 | content-irrelevant | 1 |
| 204 | contrarotational | 1 |
| 205 | cortisol-secretion | 1 |
| 206 | corus | 1 |
| 207 | cotunneling | 1 |
| 208 | counter-acculturative | 1 |
| 209 | co₄ | 1 |
| 210 | curve0-5 | 1 |
| 211 | cytoband | 1 |
| 212 | cytotrophoblast-extraembrional | 1 |
| 213 | dashte- | 1 |
| 214 | demon2k | 1 |
| 215 | deoxygenative | 1 |
| 216 | dihydroceramidase | 1 |
| 217 | distribution/clinical | 1 |
| 218 | doggy-paddle | 1 |
| 219 | dtp-based | 1 |
| 220 | duchess | 1 |
| 221 | duration-optimized | 1 |
| 222 | dysllpidaemia | 1 |
| 223 | eccentric-exercise | 1 |
| 224 | edge-controlled | 1 |
| 225 | edof-hc | 1 |
| 226 | einheitlicher | 1 |
| 227 | ekos | 1 |
| 228 | electron-nuclear | 1 |
| 229 | emaco | 1 |
| 230 | endotex | 1 |
| 231 | enzastaurin-containing | 1 |
| 232 | ep/ema | 1 |
| 233 | epi/cdd | 1 |
| 234 | eras/acerto | 1 |
| 235 | ergo-aupdnps | 1 |
| 236 | etiic1 | 1 |
| 237 | euprymna | 1 |
| 238 | europe1/south | 1 |
| 239 | evaluation/intervention | 1 |
| 240 | eversun | 1 |
| 241 | evg/ | 1 |
| 242 | evolution-based | 1 |
| 243 | exer- | 1 |
| 244 | exposure-prothrombin | 1 |
| 245 | extra-alveolar | 1 |
| 246 | fab-7 | 1 |
| 247 | faculty-or | 1 |
| 248 | far-inverted | 1 |
| 249 | fasting-refeeding | 1 |
| 250 | five-stroke | 1 |
| 251 | flow-sensing | 1 |
| 252 | fluorouracil/levamisole | 1 |
| 253 | folk-veterinary | 1 |
| 254 | four-risk | 1 |
| 255 | four-seasonal | 1 |
| 256 | four-tone | 1 |
| 257 | fungitec | 1 |
| 258 | fut2 | 1 |
| 259 | gamma-intercept | 1 |
| 260 | gastroin | 1 |
| 261 | gebauer | 1 |
| 262 | gill-thomas-cosman | 1 |
| 263 | glycerophospho-containing | 1 |
| 264 | godelieve | 1 |
| 265 | goelam1 | 1 |
| 266 | hcd-group | 1 |
| 267 | health-effective | 1 |
| 268 | helix-stabilized | 1 |
| 269 | heparin-induced-low-density | 1 |
| 270 | hexarhenium | 1 |
| 271 | hidβyat | 1 |
| 272 | hinduistically-influenced | 1 |
| 273 | hlh-94 | 1 |
| 274 | hsp90/aha1 | 1 |
| 275 | hydropyrimidine | 1 |
| 276 | icrc | 1 |
| 277 | ictv | 1 |
| 278 | imidazolium–1,2,3-triazolyl | 1 |
| 279 | independent-mode | 1 |
| 280 | indo-dutch | 1 |
| 281 | induction-phase | 1 |
| 282 | infarctual | 1 |
| 283 | inflammatory-proliferative | 1 |
| 284 | infraorder | 1 |
| 285 | injury-prone | 1 |
| 286 | inter-reversal | 1 |
| 287 | ipv-only | 1 |
| 288 | iso-standard | 1 |
| 289 | isomethylomer | 1 |
| 290 | journey-to-work | 1 |
| 291 | jplt2 | 1 |
| 292 | kauffmann'a-white | 1 |
| 293 | khiat | 1 |
| 294 | kiddy | 1 |
| 295 | kimal | 1 |
| 296 | kninska | 1 |
| 297 | korgialenio | 1 |
| 298 | ksar | 1 |
| 299 | l-and | 1 |
| 300 | labelled-line | 1 |
| 301 | lcpufa-sensing | 1 |
| 302 | lignane | 1 |
| 303 | lipase/esterase | 1 |
| 304 | lipido-colloid | 1 |
| 305 | lnh87 | 1 |
| 306 | lovastatin-alone | 1 |
| 307 | lower-rim | 1 |
| 308 | lowpathogenicity | 1 |
| 309 | lrp1b | 1 |
| 310 | m-flex | 1 |
| 311 | m-modal | 1 |
| 312 | macro-meso-micro | 1 |
| 313 | macroautophagic-deficient | 1 |
| 314 | malgasi | 1 |
| 315 | maybridge | 1 |
| 316 | metastatic-disease | 1 |
| 317 | methylmethine-linked | 1 |
| 318 | microsamples | 1 |
| 319 | microsecond/millisecond | 1 |
| 320 | mid-to-long-term | 1 |
| 321 | mip-spe-gc | 1 |
| 322 | missoula | 1 |
| 323 | mkk4-jnk3α2 | 1 |
| 324 | mkk7-jnk3α2 | 1 |
| 325 | mono-6-thioated | 1 |
| 326 | mono-hydride | 1 |
| 327 | monpa | 1 |
| 328 | morning-treatment | 1 |
| 329 | mortality-age | 1 |
| 330 | mpcr/sbe | 1 |
| 331 | mre-net | 1 |
| 332 | multi-configuration | 1 |
| 333 | multi-server | 1 |
| 334 | multiacquisition | 1 |
| 335 | multiparametric-mri | 1 |
| 336 | nasmyth | 1 |
| 337 | naughton/balke | 1 |
| 338 | newly-us-licensed | 1 |
| 339 | nf-kappab-specific | 1 |
| 340 | niedersächsisches | 1 |
| 341 | nitrogen-sensing | 1 |
| 342 | no-preparation | 1 |
| 343 | noctiluca-pyrodinium | 1 |
| 344 | non-intensified | 1 |
| 345 | non-tlim | 1 |
| 346 | nonexchanging | 1 |
| 347 | nonphlegm | 1 |
| 348 | nonvitalized | 1 |
| 349 | nopho-aml-2004 | 1 |
| 350 | not-so-low | 1 |
| 351 | nuremburg | 1 |
| 352 | nwts-5 | 1 |
| 353 | observations-the | 1 |
| 354 | oestrogen/chorionic | 1 |
| 355 | one-pill-a-day | 1 |
| 356 | one-stage-full-mouth-disinfection | 1 |
| 357 | opv-only | 1 |
| 358 | organum | 1 |
| 359 | orificium | 1 |
| 360 | osiii/osii | 1 |
| 361 | osmium-catalyzed | 1 |
| 362 | output-input | 1 |
| 363 | ovsynch/tai | 1 |
| 364 | parrodiene-derivative | 1 |
| 365 | parvomedics | 1 |
| 366 | patient/control | 1 |
| 367 | penske | 1 |
| 368 | perc-dle | 1 |
| 369 | pet/ct-based | 1 |
| 370 | phenylbenzoquinone-induced | 1 |
| 371 | physikalisch-technische | 1 |
| 372 | piezo-system | 1 |
| 373 | policlinica | 1 |
| 374 | polyamine-inhibitory | 1 |
| 375 | polysyndromic | 1 |
| 376 | polyterpene | 1 |
| 377 | post-reaming | 1 |
| 378 | pre/post-recovery | 1 |
| 379 | predator-sea | 1 |
| 380 | prehydrolysis | 1 |
| 381 | presepsis | 1 |
| 382 | pribiotic | 1 |
| 383 | principal-and | 1 |
| 384 | progesterone-combined | 1 |
| 385 | prometa | 1 |
| 386 | prometa™ | 1 |
| 387 | pseudofirst-order | 1 |
| 388 | pta-loading | 1 |
| 389 | pulse-treatment | 1 |
| 390 | pulverisation | 1 |
| 391 | ranitidine/non-ranitidine | 1 |
| 392 | redlegged | 1 |
| 393 | remel | 1 |
| 394 | retinervus | 1 |
| 395 | riskest | 1 |
| 396 | rpt-containing | 1 |
| 397 | rtog0225 | 1 |
| 398 | s-plus-based | 1 |
| 399 | sacoglossan | 1 |
| 400 | sagrado | 1 |
| 401 | sanatorio | 1 |
| 402 | santrampur | 1 |
| 403 | schroda | 1 |
| 404 | selective-time | 1 |
| 405 | self-efficacy/temptations | 1 |
| 406 | semeiographic | 1 |
| 407 | sero-immunological | 1 |
| 408 | serum-concentration | 1 |
| 409 | setose | 1 |
| 410 | sheridan-gardiner | 1 |
| 411 | shipworm | 1 |
| 412 | sierpinski | 1 |
| 413 | simvastatin-cholestyramine | 1 |
| 414 | sisstanish | 1 |
| 415 | six-tone | 1 |
| 416 | skin-operative | 1 |
| 417 | skin-skin | 1 |
| 418 | småbørns | 1 |
| 419 | solution/device | 1 |
| 420 | sotho-tswana | 1 |
| 421 | specify® | 1 |
| 422 | srim | 1 |
| 423 | stopping/release | 1 |
| 424 | storend | 1 |
| 425 | streptavidin-counterpart | 1 |
| 426 | studies.heart | 1 |
| 427 | sub-low | 1 |
| 428 | subgroup-e | 1 |
| 429 | subnasale-soft | 1 |
| 430 | sukravaha | 1 |
| 431 | sunitinib-docetaxel | 1 |
| 432 | supelclean™ | 1 |
| 433 | superior-most | 1 |
| 434 | superspecies | 1 |
| 435 | surgico-pathological | 1 |
| 436 | sv40-t/t-transformed | 1 |
| 437 | swakopmund | 1 |
| 438 | symptom-tailored | 1 |
| 439 | symptom-to-needle | 1 |
| 440 | taliban | 1 |
| 441 | tbp-interaction | 1 |
| 442 | tcdd-arachidonic | 1 |
| 443 | technogenous | 1 |
| 444 | tellurite-resistant | 1 |
| 445 | temperature-density | 1 |
| 446 | ten-dose | 1 |
| 447 | tetramanganese-substituted | 1 |
| 448 | tg-51 | 1 |
| 449 | three-dose-perioperative | 1 |
| 450 | three-triangular | 1 |
| 451 | three-yearly | 1 |
| 452 | titin-stained | 1 |
| 453 | tmb-hoono | 1 |
| 454 | tpe-based | 1 |
| 455 | transsystolic | 1 |
| 456 | tumorgraft | 1 |
| 457 | two-queue | 1 |
| 458 | typewritten | 1 |
| 459 | ultraviscous | 1 |
| 460 | unicohort | 1 |
| 461 | university-al | 1 |
| 462 | unpassivated | 1 |
| 463 | uthando | 1 |
| 464 | vdc/ice | 1 |
| 465 | vdclp | 1 |
| 466 | veliki | 1 |
| 467 | venacure | 1 |
| 468 | ventrocaudalis | 1 |
| 469 | visit/travel | 1 |
| 470 | well-term | 1 |
| 471 | westfälische | 1 |
| 472 | whitehorse | 1 |
| 473 | who/ | 1 |
| 474 | whole-cantaloupe | 1 |
| 475 | wind-dampness-heat | 1 |
| 476 | wsg | 1 |
| 477 | wuerzburger | 1 |
| 478 | ynediamines | 1 |
| 479 | «black | 1 |
| 480 | ³²p-chromic | 1 |
| 481 | µ-antagonist | 1 |
| 482 | ‘money | 1 |
| 483 | ‘normal’ | 1 |
| 484 | “single | 1 |
| 485 | ″white | 1 |
| 1 | 'bruce | 1 |
| 2 | 'capacidad | 1 |
| 3 | 'maori | 1 |
| 4 | 'modus | 1 |
| 5 | 1.88-ga | 1 |
| 6 | 10,000-step | 1 |
| 7 | 10-mg/day | 3 |
| 8 | 100-year | 2 |
| 9 | 120-question | 1 |
| 10 | 14-3-3γ/star | 1 |
| 11 | 14-3-3ζ-driven | 1 |
| 12 | 14ud | 1 |
| 13 | 150-mg/day | 5 |
| 14 | 1600-iu/d | 2 |
| 15 | 18-20-week | 2 |
| 16 | 1975-80 | 1 |
| 17 | 2-haptic | 1 |
| 18 | 2-imidazolyl-3,4-dihydroquinazolines | 2 |
| 19 | 20-mcg | 1 |
| 20 | 21/2/5 | 2 |
| 21 | 270-minute | 1 |
| 22 | 3-deoxy | 1 |
| 23 | 3-phenolic | 1 |
| 24 | 3d-rx-system | 2 |
| 25 | 3α-17 | 1 |
| 26 | 3∼5-wk | 1 |
| 27 | 4-methoxycarbonyl-2-nitrophenyl | 1 |
| 28 | 48-th | 1 |
| 29 | 5-fluorouracil/epirubicin/cyclophosphamide | 1 |
| 30 | 500-year-long | 1 |
| 31 | 6.5-week | 1 |
| 32 | 7+3+atra | 1 |
| 33 | 7-hydroxy-n-neopentyl | 1 |
| 34 | 7.47-g | 2 |
| 35 | 746-bp | 2 |
| 36 | 90-mm | 3 |
| 37 | 9931 | 2 |
| 38 | aamyc | 1 |
| 39 | above-described | 10 |
| 40 | abovementioned | 35 |
| 41 | acceptor-recognition | 1 |
| 42 | ace.1 | 1 |
| 43 | activity-sensitive | 1 |
| 44 | acute-cyclic | 1 |
| 45 | advaita | 1 |
| 46 | adyayana | 1 |
| 47 | afore-mentioned | 5 |
| 48 | al-mu'alajat | 2 |
| 49 | alarme | 1 |
| 50 | ald-enabled | 1 |
| 51 | all-96 | 1 |
| 52 | all-loop | 1 |
| 53 | all-placebo | 2 |
| 54 | all-sutures-out | 2 |
| 55 | allophonic | 1 |
| 56 | allyl-modified | 1 |
| 57 | alumina-bearing | 1 |
| 58 | amborella | 1 |
| 59 | amprenavir-ritonavir | 1 |
| 60 | anangu | 1 |
| 61 | anatomische | 2 |
| 62 | anatomy-guided | 1 |
| 63 | andon | 3 |
| 64 | anti-h6n1 | 1 |
| 65 | antiprotéases | 1 |
| 66 | apartheid | 3 |
| 67 | apoe-apoc1-apoc4-apoc2 | 2 |
| 68 | aprepitant-containing | 1 |
| 69 | arf-gap | 1 |
| 70 | artiview® | 1 |
| 71 | asia-oceania | 1 |
| 72 | assi | 1 |
| 73 | atazanavir/ritonavir-based | 1 |
| 74 | athas | 2 |
| 75 | attitude-social | 2 |
| 76 | augmented-correlation | 1 |
| 77 | avoid-intubation | 1 |
| 78 | ba-sic | 1 |
| 79 | bac- | 1 |
| 80 | balke-ware | 1 |
| 81 | barber-based | 1 |
| 82 | baseline/12-month | 1 |
| 83 | batch-sampling | 1 |
| 84 | baylor-methodist | 2 |
| 85 | beloved | 2 |
| 86 | benthopelagic | 1 |
| 87 | bertinot | 1 |
| 88 | best-documented | 15 |
| 89 | best-researched | 4 |
| 90 | best-studied | 23 |
| 91 | beta-exotoxin | 1 |
| 92 | bewitching | 1 |
| 93 | bex | 2 |
| 94 | bfm-95 | 1 |
| 95 | bh4-perfused | 2 |
| 96 | bis-electrophiles | 1 |
| 97 | bittery | 1 |
| 98 | blue-field | 3 |
| 99 | bluff | 5 |
| 100 | boo-rich | 1 |
| 101 | breakthough | 1 |
| 102 | c-seal | 7 |
| 103 | calcisponge | 1 |
| 104 | callicrate | 1 |
| 105 | carbamazepine-dosing | 1 |
| 106 | carl-gustav | 1 |
| 107 | carnic | 1 |
| 108 | casuistics | 1 |
| 109 | cathetec | 1 |
| 110 | cbf-targeted | 3 |
| 111 | cbs-qb3 | 6 |
| 112 | cd33+/hla | 1 |
| 113 | cdc-recommended | 1 |
| 114 | cdc/acsm | 4 |
| 115 | ceausescu | 1 |
| 116 | cenex | 1 |
| 117 | chambery | 2 |
| 118 | charge-separating | 1 |
| 119 | charoi | 1 |
| 120 | chemotheurapeutic | 1 |
| 121 | china-recommended | 5 |
| 122 | clarithromycin-nitroimidazole | 1 |
| 123 | closely-supervised | 2 |
| 124 | cmv-preventive | 1 |
| 125 | cnrl | 1 |
| 126 | cognition-centered | 1 |
| 127 | coitus-treatment | 1 |
| 128 | compactin-cholestyramine | 1 |
| 129 | comptes | 1 |
| 130 | content-irrelevant | 1 |
| 131 | contrarotational | 1 |
| 132 | cortisol-secretion | 1 |
| 133 | corus | 1 |
| 134 | cotunneling | 1 |
| 135 | counter-acculturative | 1 |
| 136 | co₄ | 1 |
| 137 | curve0-5 | 1 |
| 138 | cytoband | 1 |
| 139 | cytotrophoblast-extraembrional | 1 |
| 140 | dashte- | 1 |
| 141 | demon2k | 1 |
| 142 | deoxygenative | 1 |
| 143 | dihydroceramidase | 1 |
| 144 | distribution/clinical | 1 |
| 145 | doggy-paddle | 1 |
| 146 | dtp-based | 1 |
| 147 | duchess | 1 |
| 148 | duration-optimized | 1 |
| 149 | dysllpidaemia | 1 |
| 150 | e-screen | 5 |
| 151 | eccentric-exercise | 1 |
| 152 | edge-controlled | 1 |
| 153 | edof-hc | 1 |
| 154 | effect-lasting | 2 |
| 155 | egd-colonoscopy | 2 |
| 156 | einheitlicher | 1 |
| 157 | ekos | 1 |
| 158 | electron-nuclear | 1 |
| 159 | emaco | 1 |
| 160 | endotex | 1 |
| 161 | enzastaurin-containing | 1 |
| 162 | ep/ema | 1 |
| 163 | epi/cdd | 1 |
| 164 | eras/acerto | 1 |
| 165 | ergo-aupdnps | 1 |
| 166 | etiic1 | 1 |
| 167 | euprymna | 1 |
| 168 | europe1/south | 1 |
| 169 | evaluation/intervention | 1 |
| 170 | eversun | 1 |
| 171 | evg/ | 1 |
| 172 | evolution-based | 1 |
| 173 | exer- | 1 |
| 174 | exposure-prothrombin | 1 |
| 175 | extra-alveolar | 1 |
| 176 | fab-7 | 1 |
| 177 | faculty-or | 1 |
| 178 | far-inverted | 1 |
| 179 | fasting-refeeding | 1 |
| 180 | firebird2 | 2 |
| 181 | first-flush | 8 |
| 182 | first-person-shooter-video-game | 2 |
| 183 | first-quartile | 2 |
| 184 | fitfor2 | 2 |
| 185 | fittest | 9 |
| 186 | five-stroke | 1 |
| 187 | flow-sensing | 1 |
| 188 | fluorouracil/levamisole | 1 |
| 189 | folk-veterinary | 1 |
| 190 | form-only | 3 |
| 191 | four-risk | 1 |
| 192 | four-seasonal | 1 |
| 193 | four-tone | 1 |
| 194 | fungitec | 1 |
| 195 | furopyridine | 2 |
| 196 | fut2 | 1 |
| 197 | gamma-intercept | 1 |
| 198 | gastroin | 1 |
| 199 | gebauer | 1 |
| 200 | gill-thomas-cosman | 1 |
| 201 | glycerophospho-containing | 1 |
| 202 | godelieve | 1 |
| 203 | goelam1 | 1 |
| 204 | half-order | 2 |
| 205 | hcd-group | 1 |
| 206 | health-effective | 1 |
| 207 | helix-stabilized | 1 |
| 208 | heparin-induced-low-density | 1 |
| 209 | hexarhenium | 1 |
| 210 | hidβyat | 1 |
| 211 | higher-dosage | 2 |
| 212 | hinduistically-influenced | 1 |
| 213 | hlh-94 | 1 |
| 214 | hsp90/aha1 | 1 |
| 215 | hvj-liposome-carrying | 2 |
| 216 | hydropyrimidine | 1 |
| 217 | hypovirus-infected | 2 |
| 218 | icrc | 1 |
| 219 | ictv | 1 |
| 220 | imidazolium–1,2,3-triazolyl | 1 |
| 221 | independent-mode | 1 |
| 222 | indo-dutch | 1 |
| 223 | induction-phase | 1 |
| 224 | infarctual | 1 |
| 225 | inflammatory-proliferative | 1 |
| 226 | infraorder | 1 |
| 227 | inh-rpt | 2 |
| 228 | injury-prone | 1 |
| 229 | inter-epidemic | 2 |
| 230 | inter-reversal | 1 |
| 231 | interwar | 3 |
| 232 | intial | 2 |
| 233 | ipv-only | 1 |
| 234 | irregularly-shaped | 2 |
| 235 | iso-standard | 1 |
| 236 | isomethylomer | 1 |
| 237 | its1/5.8s | 2 |
| 238 | jeryl | 2 |
| 239 | joaquín | 2 |
| 240 | journey-to-work | 1 |
| 241 | jplt2 | 1 |
| 242 | kauffmann'a-white | 1 |
| 243 | khiat | 1 |
| 244 | kiddy | 1 |
| 245 | kimal | 1 |
| 246 | kninska | 1 |
| 247 | korgialenio | 1 |
| 248 | ksar | 1 |
| 249 | l-and | 1 |
| 250 | labelled-line | 1 |
| 251 | lcpufa-sensing | 1 |
| 252 | lignane | 1 |
| 253 | lipase/esterase | 1 |
| 254 | lipido-colloid | 1 |
| 255 | lnh87 | 1 |
| 256 | longli | 2 |
| 257 | lovastatin-alone | 1 |
| 258 | lower-rim | 1 |
| 259 | lowpathogenicity | 1 |
| 260 | lrp1b | 1 |
| 261 | m-flex | 1 |
| 262 | m-modal | 1 |
| 263 | macro-meso-micro | 1 |
| 264 | macroautophagic-deficient | 1 |
| 265 | malgasi | 1 |
| 266 | mapé | 2 |
| 267 | maybridge | 1 |
| 268 | maylard | 2 |
| 269 | metastatic-disease | 1 |
| 270 | methylmethine-linked | 1 |
| 271 | microsamples | 1 |
| 272 | microsecond/millisecond | 1 |
| 273 | mid-to-long-term | 1 |
| 274 | mip-spe-gc | 1 |
| 275 | missoula | 1 |
| 276 | miyahira-araujo | 3 |
| 277 | mkk4-jnk3α2 | 1 |
| 278 | mkk7-jnk3α2 | 1 |
| 279 | mn4cao5 | 4 |
| 280 | mono-6-thioated | 1 |
| 281 | mono-hydride | 1 |
| 282 | monpa | 1 |
| 283 | morning-treatment | 1 |
| 284 | morning/morning | 3 |
| 285 | mortality-age | 1 |
| 286 | most-effective | 4 |
| 287 | mpcr/sbe | 1 |
| 288 | mre-net | 1 |
| 289 | multi-configuration | 1 |
| 290 | multi-server | 1 |
| 291 | multiacquisition | 1 |
| 292 | multiparametric-mri | 1 |
| 293 | nasmyth | 1 |
| 294 | naughton/balke | 1 |
| 295 | neurosky | 2 |
| 296 | newly-discovered | 3 |
| 297 | newly-us-licensed | 1 |
| 298 | nf-kappab-specific | 1 |
| 299 | niedersächsisches | 1 |
| 300 | nitrogen-sensing | 1 |
| 301 | no-preparation | 1 |
| 302 | noctiluca-pyrodinium | 1 |
| 303 | nomological | 2 |
| 304 | non-intensified | 1 |
| 305 | non-tlim | 1 |
| 306 | nonexchanging | 1 |
| 307 | nonphlegm | 1 |
| 308 | nonvitalized | 1 |
| 309 | nopho-aml-2004 | 1 |
| 310 | not-so-low | 1 |
| 311 | nuremburg | 1 |
| 312 | nwts-5 | 1 |
| 313 | observations-the | 1 |
| 314 | oestrogen/chorionic | 1 |
| 315 | onderlinge | 2 |
| 316 | ondokuz | 2 |
| 317 | one-needle | 2 |
| 318 | one-pill-a-day | 1 |
| 319 | one-stage-full-mouth-disinfection | 1 |
| 320 | onset-to-onset | 4 |
| 321 | opv-only | 1 |
| 322 | organum | 1 |
| 323 | orificium | 1 |
| 324 | osiii/osii | 1 |
| 325 | osmium-catalyzed | 1 |
| 326 | output-input | 1 |
| 327 | ovsynch/tai | 1 |
| 328 | pani-bi₂te₃ | 2 |
| 329 | parrodiene-derivative | 1 |
| 330 | parvomedics | 1 |
| 331 | patient/control | 1 |
| 332 | penske | 1 |
| 333 | perc-dle | 1 |
| 334 | pet/ct-based | 1 |
| 335 | phenylbenzoquinone-induced | 1 |
| 336 | physikalisch-technische | 1 |
| 337 | piezo-system | 1 |
| 338 | policlinica | 1 |
| 339 | polyamine-inhibitory | 1 |
| 340 | polysyndromic | 1 |
| 341 | polyterpene | 1 |
| 342 | post-reaming | 1 |
| 343 | pre-ischaemic | 2 |
| 344 | pre-vte | 2 |
| 345 | pre/post-recovery | 1 |
| 346 | predator-sea | 1 |
| 347 | prehydrolysis | 1 |
| 348 | premicellar | 2 |
| 349 | presepsis | 1 |
| 350 | pribiotic | 1 |
| 351 | principal-and | 1 |
| 352 | progesterone-combined | 1 |
| 353 | prometa | 1 |
| 354 | prometa™ | 1 |
| 355 | pseudofirst-order | 1 |
| 356 | pta-loading | 1 |
| 357 | pulse-treatment | 1 |
| 358 | pulverisation | 1 |
| 359 | pyloriset | 2 |
| 360 | r-packages | 2 |
| 361 | raison | 2 |
| 362 | ranitidine/non-ranitidine | 1 |
| 363 | ravasio | 3 |
| 364 | rbv-containing | 2 |
| 365 | redlegged | 1 |
| 366 | remel | 1 |
| 367 | remigium | 2 |
| 368 | resistance-band | 2 |
| 369 | retinervus | 1 |
| 370 | riskest | 1 |
| 371 | rpt-containing | 1 |
| 372 | rtog0225 | 1 |
| 373 | s-plus-based | 1 |
| 374 | sacoglossan | 1 |
| 375 | sagrado | 1 |
| 376 | same | 23,627 |
| 377 | sanatorio | 1 |
| 378 | santrampur | 1 |
| 379 | schroda | 1 |
| 380 | selective-time | 1 |
| 381 | self-efficacy/temptations | 1 |
| 382 | semeiographic | 1 |
| 383 | senescing | 2 |
| 384 | sero-immunological | 1 |
| 385 | serum-concentration | 1 |
| 386 | setose | 1 |
| 387 | sheridan-gardiner | 1 |
| 388 | shipworm | 1 |
| 389 | sierpinski | 1 |
| 390 | signature™ | 2 |
| 391 | sigrid | 3 |
| 392 | simvastatin-cholestyramine | 1 |
| 393 | sisstanish | 1 |
| 394 | six-tone | 1 |
| 395 | skin-operative | 1 |
| 396 | skin-skin | 1 |
| 397 | smetankin | 2 |
| 398 | småbørns | 1 |
| 399 | solution/device | 1 |
| 400 | sotho-tswana | 1 |
| 401 | specify® | 1 |
| 402 | spma-spmb | 2 |
| 403 | srim | 1 |
| 404 | stmp-treated | 2 |
| 405 | stopping/release | 1 |
| 406 | storend | 1 |
| 407 | streptavidin-counterpart | 1 |
| 408 | studies.heart | 1 |
| 409 | sub-low | 1 |
| 410 | subgroup-e | 1 |
| 411 | subnasale-soft | 1 |
| 412 | sukravaha | 1 |
| 413 | sunitinib-docetaxel | 1 |
| 414 | supelclean™ | 1 |
| 415 | superior-most | 1 |
| 416 | superspecies | 1 |
| 417 | surgico-pathological | 1 |
| 418 | sv40-t/t-transformed | 1 |
| 419 | swakopmund | 1 |
| 420 | symptom-tailored | 1 |
| 421 | symptom-to-needle | 1 |
| 422 | syntax-le | 2 |
| 423 | taliban | 1 |
| 424 | tbp-interaction | 1 |
| 425 | tcdd-arachidonic | 1 |
| 426 | teamstepps | 2 |
| 427 | technische | 3 |
| 428 | technogenous | 1 |
| 429 | tellurite-resistant | 1 |
| 430 | temperature-density | 1 |
| 431 | ten-dose | 1 |
| 432 | tetramanganese-substituted | 1 |
| 433 | tg-51 | 1 |
| 434 | three-dose-perioperative | 1 |
| 435 | three-triangular | 1 |
| 436 | three-yearly | 1 |
| 437 | titin-stained | 1 |
| 438 | tmb-hoono | 1 |
| 439 | toruzyme | 2 |
| 440 | tpe-based | 1 |
| 441 | trans-amino | 3 |
| 442 | transsystolic | 1 |
| 443 | traumaman | 3 |
| 444 | traumaregistry | 2 |
| 445 | trec-enriched | 2 |
| 446 | tumorgraft | 1 |
| 447 | two-queue | 1 |
| 448 | typewritten | 1 |
| 449 | ultraviscous | 1 |
| 450 | unicohort | 1 |
| 451 | university-al | 1 |
| 452 | unpassivated | 1 |
| 453 | uthando | 1 |
| 454 | vdc/ice | 1 |
| 455 | vdclp | 1 |
| 456 | veliki | 1 |
| 457 | venacure | 1 |
| 458 | venotrain | 2 |
| 459 | ventrocaudalis | 1 |
| 460 | vibration-to-translation | 2 |
| 461 | visit/travel | 1 |
| 462 | want2work | 2 |
| 463 | well-term | 1 |
| 464 | westfälische | 1 |
| 465 | whitehorse | 1 |
| 466 | who/ | 1 |
| 467 | whole-cantaloupe | 1 |
| 468 | whole-group | 3 |
| 469 | wind-dampness-heat | 1 |
| 470 | wsg | 1 |
| 471 | wuerzburger | 1 |
| 472 | xeni | 2 |
| 473 | ynediamines | 1 |
| 474 | zebris | 2 |
| 475 | «black | 1 |
| 476 | ³²p-chromic | 1 |
| 477 | µ-antagonist | 1 |
| 478 | ştei-băiţa | 4 |
| 479 | β-arrestin-2-assembled | 2 |
| 480 | δ0 | 2 |
| 481 | δtpia | 6 |
| 482 | ‘money | 1 |
| 483 | ‘normal’ | 1 |
| 484 | “single | 1 |
| 485 | ″white | 1 |
| 1 | bac- | 1 |
| 2 | dashte- | 1 |
| 3 | exer- | 1 |
| 4 | evg/ | 1 |
| 5 | who/ | 1 |
| 6 | 1975-80 | 1 |
| 7 | δ0 | 2 |
| 8 | ace.1 | 1 |
| 9 | 9931 | 2 |
| 10 | tg-51 | 1 |
| 11 | hsp90/aha1 | 1 |
| 12 | etiic1 | 1 |
| 13 | goelam1 | 1 |
| 14 | anti-h6n1 | 1 |
| 15 | apoe-apoc1-apoc4-apoc2 | 2 |
| 16 | firebird2 | 2 |
| 17 | fitfor2 | 2 |
| 18 | jplt2 | 1 |
| 19 | fut2 | 1 |
| 20 | mkk4-jnk3α2 | 1 |
| 21 | mkk7-jnk3α2 | 1 |
| 22 | cbs-qb3 | 6 |
| 23 | nopho-aml-2004 | 1 |
| 24 | hlh-94 | 1 |
| 25 | curve0-5 | 1 |
| 26 | nwts-5 | 1 |
| 27 | 21/2/5 | 2 |
| 28 | rtog0225 | 1 |
| 29 | bfm-95 | 1 |
| 30 | mn4cao5 | 4 |
| 31 | all-96 | 1 |
| 32 | fab-7 | 1 |
| 33 | 3α-17 | 1 |
| 34 | lnh87 | 1 |
| 35 | policlinica | 1 |
| 36 | schroda | 1 |
| 37 | predator-sea | 1 |
| 38 | 1.88-ga | 1 |
| 39 | sukravaha | 1 |
| 40 | dysllpidaemia | 1 |
| 41 | asia-oceania | 1 |
| 42 | δtpia | 6 |
| 43 | kninska | 1 |
| 44 | cd33+/hla | 1 |
| 45 | amborella | 1 |
| 46 | missoula | 1 |
| 47 | ep/ema | 1 |
| 48 | sotho-tswana | 1 |
| 49 | adyayana | 1 |
| 50 | euprymna | 1 |
| 51 | monpa | 1 |
| 52 | 7+3+atra | 1 |
| 53 | prometa | 1 |
| 54 | advaita | 1 |
| 55 | ştei-băiţa | 4 |
| 56 | lrp1b | 1 |
| 57 | spma-spmb | 2 |
| 58 | cathetec | 1 |
| 59 | fungitec | 1 |
| 60 | mip-spe-gc | 1 |
| 61 | edof-hc | 1 |
| 62 | nf-kappab-specific | 1 |
| 63 | benthopelagic | 1 |
| 64 | semeiographic | 1 |
| 65 | acute-cyclic | 1 |
| 66 | 3-phenolic | 1 |
| 67 | transsystolic | 1 |
| 68 | pre-ischaemic | 2 |
| 69 | inter-epidemic | 2 |
| 70 | polysyndromic | 1 |
| 71 | ³²p-chromic | 1 |
| 72 | tcdd-arachidonic | 1 |
| 73 | allophonic | 1 |
| 74 | oestrogen/chorionic | 1 |
| 75 | carnic | 1 |
| 76 | ba-sic | 1 |
| 77 | pribiotic | 1 |
| 78 | 2-haptic | 1 |
| 79 | chemotheurapeutic | 1 |
| 80 | icrc | 1 |
| 81 | aamyc | 1 |
| 82 | 1600-iu/d | 2 |
| 83 | 'capacidad | 1 |
| 84 | epi/cdd | 1 |
| 85 | above-described | 10 |
| 86 | hinduistically-influenced | 1 |
| 87 | phenylbenzoquinone-induced | 1 |
| 88 | anatomy-guided | 1 |
| 89 | china-recommended | 5 |
| 90 | cdc-recommended | 1 |
| 91 | redlegged | 1 |
| 92 | trec-enriched | 2 |
| 93 | best-researched | 4 |
| 94 | best-studied | 23 |
| 95 | allyl-modified | 1 |
| 96 | non-intensified | 1 |
| 97 | methylmethine-linked | 1 |
| 98 | ald-enabled | 1 |
| 99 | β-arrestin-2-assembled | 2 |
| 100 | edge-controlled | 1 |
| 101 | sv40-t/t-transformed | 1 |
| 102 | titin-stained | 1 |
| 103 | progesterone-combined | 1 |
| 104 | afore-mentioned | 5 |
| 105 | abovementioned | 35 |
| 106 | irregularly-shaped | 2 |
| 107 | cognition-centered | 1 |
| 108 | newly-discovered | 3 |
| 109 | symptom-tailored | 1 |
| 110 | tpe-based | 1 |
| 111 | evolution-based | 1 |
| 112 | dtp-based | 1 |
| 113 | barber-based | 1 |
| 114 | atazanavir/ritonavir-based | 1 |
| 115 | s-plus-based | 1 |
| 116 | pet/ct-based | 1 |
| 117 | closely-supervised | 2 |
| 118 | newly-us-licensed | 1 |
| 119 | bh4-perfused | 2 |
| 120 | stmp-treated | 2 |
| 121 | mono-6-thioated | 1 |
| 122 | unpassivated | 1 |
| 123 | hypovirus-infected | 2 |
| 124 | cbf-targeted | 3 |
| 125 | best-documented | 15 |
| 126 | far-inverted | 1 |
| 127 | tetramanganese-substituted | 1 |
| 128 | beloved | 2 |
| 129 | nonvitalized | 1 |
| 130 | helix-stabilized | 1 |
| 131 | duration-optimized | 1 |
| 132 | osmium-catalyzed | 1 |
| 133 | apartheid | 3 |
| 134 | lipido-colloid | 1 |
| 135 | sigrid | 3 |
| 136 | blue-field | 3 |
| 137 | l-and | 1 |
| 138 | principal-and | 1 |
| 139 | resistance-band | 2 |
| 140 | cytoband | 1 |
| 141 | storend | 1 |
| 142 | microsecond/millisecond | 1 |
| 143 | swakopmund | 1 |
| 144 | iso-standard | 1 |
| 145 | maylard | 2 |
| 146 | 14ud | 1 |
| 147 | subgroup-e | 1 |
| 148 | mpcr/sbe | 1 |
| 149 | vdc/ice | 1 |
| 150 | solution/device | 1 |
| 151 | 'bruce | 1 |
| 152 | 5-fluorouracil/epirubicin/cyclophosphamide | 1 |
| 153 | mono-hydride | 1 |
| 154 | independent-mode | 1 |
| 155 | mortality-age | 1 |
| 156 | higher-dosage | 2 |
| 157 | maybridge | 1 |
| 158 | onderlinge | 2 |
| 159 | calcisponge | 1 |
| 160 | westfälische | 1 |
| 161 | anatomische | 2 |
| 162 | technische | 3 |
| 163 | physikalisch-technische | 1 |
| 164 | observations-the | 1 |
| 165 | naughton/balke | 1 |
| 166 | five-stroke | 1 |
| 167 | penske | 1 |
| 168 | syntax-le | 2 |
| 169 | perc-dle | 1 |
| 170 | doggy-paddle | 1 |
| 171 | one-needle | 2 |
| 172 | symptom-to-needle | 1 |
| 173 | “single | 1 |
| 174 | first-quartile | 2 |
| 175 | fluorouracil/levamisole | 1 |
| 176 | clarithromycin-nitroimidazole | 1 |
| 177 | first-person-shooter-video-game | 2 |
| 178 | same | 23,627 |
| 179 | selective-time | 1 |
| 180 | alarme | 1 |
| 181 | toruzyme | 2 |
| 182 | lignane | 1 |
| 183 | polyterpene | 1 |
| 184 | hydropyrimidine | 1 |
| 185 | furopyridine | 2 |
| 186 | ranitidine/non-ranitidine | 1 |
| 187 | labelled-line | 1 |
| 188 | simvastatin-cholestyramine | 1 |
| 189 | compactin-cholestyramine | 1 |
| 190 | lovastatin-alone | 1 |
| 191 | injury-prone | 1 |
| 192 | four-tone | 1 |
| 193 | six-tone | 1 |
| 194 | whole-cantaloupe | 1 |
| 195 | balke-ware | 1 |
| 196 | venacure | 1 |
| 197 | dihydroceramidase | 1 |
| 198 | stopping/release | 1 |
| 199 | metastatic-disease | 1 |
| 200 | induction-phase | 1 |
| 201 | lipase/esterase | 1 |
| 202 | eccentric-exercise | 1 |
| 203 | ten-dose | 1 |
| 204 | setose | 1 |
| 205 | whitehorse | 1 |
| 206 | callicrate | 1 |
| 207 | kauffmann'a-white | 1 |
| 208 | ″white | 1 |
| 209 | 270-minute | 1 |
| 210 | pre-vte | 2 |
| 211 | two-queue | 1 |
| 212 | godelieve | 1 |
| 213 | deoxygenative | 1 |
| 214 | inflammatory-proliferative | 1 |
| 215 | skin-operative | 1 |
| 216 | three-dose-perioperative | 1 |
| 217 | counter-acculturative | 1 |
| 218 | parrodiene-derivative | 1 |
| 219 | health-effective | 1 |
| 220 | most-effective | 4 |
| 221 | activity-sensitive | 1 |
| 222 | cmv-preventive | 1 |
| 223 | bluff | 5 |
| 224 | 7.47-g | 2 |
| 225 | 20-mcg | 1 |
| 226 | senescing | 2 |
| 227 | pta-loading | 1 |
| 228 | fasting-refeeding | 1 |
| 229 | nonexchanging | 1 |
| 230 | bewitching | 1 |
| 231 | cotunneling | 1 |
| 232 | batch-sampling | 1 |
| 233 | post-reaming | 1 |
| 234 | enzastaurin-containing | 1 |
| 235 | glycerophospho-containing | 1 |
| 236 | aprepitant-containing | 1 |
| 237 | rpt-containing | 1 |
| 238 | rbv-containing | 2 |
| 239 | morning/morning | 3 |
| 240 | alumina-bearing | 1 |
| 241 | lcpufa-sensing | 1 |
| 242 | nitrogen-sensing | 1 |
| 243 | flow-sensing | 1 |
| 244 | carbamazepine-dosing | 1 |
| 245 | charge-separating | 1 |
| 246 | effect-lasting | 2 |
| 247 | hvj-liposome-carrying | 2 |
| 248 | 500-year-long | 1 |
| 249 | nuremburg | 1 |
| 250 | wsg | 1 |
| 251 | boo-rich | 1 |
| 252 | indo-dutch | 1 |
| 253 | breakthough | 1 |
| 254 | sisstanish | 1 |
| 255 | first-flush | 8 |
| 256 | 48-th | 1 |
| 257 | baseline/12-month | 1 |
| 258 | europe1/south | 1 |
| 259 | nasmyth | 1 |
| 260 | ovsynch/tai | 1 |
| 261 | osiii/osii | 1 |
| 262 | veliki | 1 |
| 263 | sierpinski | 1 |
| 264 | longli | 2 |
| 265 | xeni | 2 |
| 266 | charoi | 1 |
| 267 | multiparametric-mri | 1 |
| 268 | 'maori | 1 |
| 269 | malgasi | 1 |
| 270 | assi | 1 |
| 271 | demon2k | 1 |
| 272 | «black | 1 |
| 273 | 18-20-week | 2 |
| 274 | 6.5-week | 1 |
| 275 | journey-to-work | 1 |
| 276 | want2work | 2 |
| 277 | four-risk | 1 |
| 278 | 3∼5-wk | 1 |
| 279 | university-al | 1 |
| 280 | surgico-pathological | 1 |
| 281 | nomological | 2 |
| 282 | sero-immunological | 1 |
| 283 | distribution/clinical | 1 |
| 284 | m-modal | 1 |
| 285 | c-seal | 7 |
| 286 | attitude-social | 2 |
| 287 | intial | 2 |
| 288 | kimal | 1 |
| 289 | cytotrophoblast-extraembrional | 1 |
| 290 | contrarotational | 1 |
| 291 | four-seasonal | 1 |
| 292 | inter-reversal | 1 |
| 293 | infarctual | 1 |
| 294 | remel | 1 |
| 295 | visit/travel | 1 |
| 296 | sunitinib-docetaxel | 1 |
| 297 | patient/control | 1 |
| 298 | cnrl | 1 |
| 299 | imidazolium–1,2,3-triazolyl | 1 |
| 300 | 4-methoxycarbonyl-2-nitrophenyl | 1 |
| 301 | jeryl | 2 |
| 302 | 7-hydroxy-n-neopentyl | 1 |
| 303 | piezo-system | 1 |
| 304 | 3d-rx-system | 2 |
| 305 | nonphlegm | 1 |
| 306 | non-tlim | 1 |
| 307 | lower-rim | 1 |
| 308 | srim | 1 |
| 309 | 90-mm | 3 |
| 310 | mid-to-long-term | 1 |
| 311 | well-term | 1 |
| 312 | shipworm | 1 |
| 313 | cdc/acsm | 4 |
| 314 | orificium | 1 |
| 315 | remigium | 2 |
| 316 | hexarhenium | 1 |
| 317 | noctiluca-pyrodinium | 1 |
| 318 | organum | 1 |
| 319 | taliban | 1 |
| 320 | traumaman | 3 |
| 321 | gill-thomas-cosman | 1 |
| 322 | sacoglossan | 1 |
| 323 | e-screen | 5 |
| 324 | typewritten | 1 |
| 325 | 14-3-3ζ-driven | 1 |
| 326 | venotrain | 2 |
| 327 | exposure-prothrombin | 1 |
| 328 | smetankin | 2 |
| 329 | skin-skin | 1 |
| 330 | gastroin | 1 |
| 331 | beta-exotoxin | 1 |
| 332 | andon | 3 |
| 333 | avoid-intubation | 1 |
| 334 | augmented-correlation | 1 |
| 335 | vibration-to-translation | 2 |
| 336 | no-preparation | 1 |
| 337 | serum-concentration | 1 |
| 338 | multi-configuration | 1 |
| 339 | pulverisation | 1 |
| 340 | tbp-interaction | 1 |
| 341 | one-stage-full-mouth-disinfection | 1 |
| 342 | cortisol-secretion | 1 |
| 343 | acceptor-recognition | 1 |
| 344 | multiacquisition | 1 |
| 345 | evaluation/intervention | 1 |
| 346 | 120-question | 1 |
| 347 | raison | 2 |
| 348 | eversun | 1 |
| 349 | joaquín | 2 |
| 350 | all-placebo | 2 |
| 351 | emaco | 1 |
| 352 | sagrado | 1 |
| 353 | uthando | 1 |
| 354 | korgialenio | 1 |
| 355 | sanatorio | 1 |
| 356 | ravasio | 3 |
| 357 | miyahira-araujo | 3 |
| 358 | trans-amino | 3 |
| 359 | tmb-hoono | 1 |
| 360 | macro-meso-micro | 1 |
| 361 | eras/acerto | 1 |
| 362 | arf-gap | 1 |
| 363 | 746-bp | 2 |
| 364 | 10,000-step | 1 |
| 365 | vdclp | 1 |
| 366 | all-loop | 1 |
| 367 | hcd-group | 1 |
| 368 | whole-group | 3 |
| 369 | electron-nuclear | 1 |
| 370 | 100-year | 2 |
| 371 | premicellar | 2 |
| 372 | extra-alveolar | 1 |
| 373 | three-triangular | 1 |
| 374 | ksar | 1 |
| 375 | 14-3-3γ/star | 1 |
| 376 | interwar | 3 |
| 377 | half-order | 2 |
| 378 | pseudofirst-order | 1 |
| 379 | infraorder | 1 |
| 380 | wuerzburger | 1 |
| 381 | einheitlicher | 1 |
| 382 | isomethylomer | 1 |
| 383 | sheridan-gardiner | 1 |
| 384 | gebauer | 1 |
| 385 | multi-server | 1 |
| 386 | amprenavir-ritonavir | 1 |
| 387 | faculty-or | 1 |
| 388 | santrampur | 1 |
| 389 | its1/5.8s | 2 |
| 390 | athas | 2 |
| 391 | parvomedics | 1 |
| 392 | casuistics | 1 |
| 393 | r-packages | 2 |
| 394 | niedersächsisches | 1 |
| 395 | superspecies | 1 |
| 396 | bis-electrophiles | 1 |
| 397 | microsamples | 1 |
| 398 | 2-imidazolyl-3,4-dihydroquinazolines | 2 |
| 399 | ynediamines | 1 |
| 400 | antiprotéases | 1 |
| 401 | comptes | 1 |
| 402 | ventrocaudalis | 1 |
| 403 | zebris | 2 |
| 404 | presepsis | 1 |
| 405 | prehydrolysis | 1 |
| 406 | self-efficacy/temptations | 1 |
| 407 | småbørns | 1 |
| 408 | ekos | 1 |
| 409 | ergo-aupdnps | 1 |
| 410 | teamstepps | 2 |
| 411 | duchess | 1 |
| 412 | 'modus | 1 |
| 413 | ultraviscous | 1 |
| 414 | technogenous | 1 |
| 415 | corus | 1 |
| 416 | retinervus | 1 |
| 417 | wind-dampness-heat | 1 |
| 418 | khiat | 1 |
| 419 | al-mu'alajat | 2 |
| 420 | hidβyat | 1 |
| 421 | mre-net | 1 |
| 422 | pyloriset | 2 |
| 423 | onset-to-onset | 4 |
| 424 | tumorgraft | 1 |
| 425 | subnasale-soft | 1 |
| 426 | tellurite-resistant | 1 |
| 427 | content-irrelevant | 1 |
| 428 | macroautophagic-deficient | 1 |
| 429 | pulse-treatment | 1 |
| 430 | morning-treatment | 1 |
| 431 | coitus-treatment | 1 |
| 432 | bertinot | 1 |
| 433 | gamma-intercept | 1 |
| 434 | inh-rpt | 2 |
| 435 | studies.heart | 1 |
| 436 | streptavidin-counterpart | 1 |
| 437 | unicohort | 1 |
| 438 | riskest | 1 |
| 439 | fittest | 9 |
| 440 | baylor-methodist | 2 |
| 441 | µ-antagonist | 1 |
| 442 | superior-most | 1 |
| 443 | all-sutures-out | 2 |
| 444 | output-input | 1 |
| 445 | ceausescu | 1 |
| 446 | anangu | 1 |
| 447 | carl-gustav | 1 |
| 448 | ictv | 1 |
| 449 | sub-low | 1 |
| 450 | not-so-low | 1 |
| 451 | bex | 2 |
| 452 | m-flex | 1 |
| 453 | cenex | 1 |
| 454 | endotex | 1 |
| 455 | one-pill-a-day | 1 |
| 456 | 10-mg/day | 3 |
| 457 | 150-mg/day | 5 |
| 458 | kiddy | 1 |
| 459 | ‘money | 1 |
| 460 | neurosky | 2 |
| 461 | form-only | 3 |
| 462 | ipv-only | 1 |
| 463 | opv-only | 1 |
| 464 | three-yearly | 1 |
| 465 | egd-colonoscopy | 2 |
| 466 | folk-veterinary | 1 |
| 467 | chambery | 2 |
| 468 | bittery | 1 |
| 469 | pre/post-recovery | 1 |
| 470 | polyamine-inhibitory | 1 |
| 471 | traumaregistry | 2 |
| 472 | lowpathogenicity | 1 |
| 473 | temperature-density | 1 |
| 474 | heparin-induced-low-density | 1 |
| 475 | 3-deoxy | 1 |
| 476 | ondokuz | 2 |
| 477 | pani-bi₂te₃ | 2 |
| 478 | co₄ | 1 |
| 479 | ‘normal’ | 1 |
| 480 | prometa™ | 1 |
| 481 | signature™ | 2 |
| 482 | supelclean™ | 1 |
| 483 | mapé | 2 |
| 484 | artiview® | 1 |
| 485 | specify® | 1 |